AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: big pharmaClear filter
industryMSN

Novo Nordisk’s OpenAI Deal Shows Big Pharma Still Wants a Shortcut to Discovery

Novo Nordisk’s partnership with OpenAI reflects the increasing willingness of major drugmakers to use general-purpose AI companies in core R&D workflows. The deal highlights a growing belief that large language and multimodal systems can accelerate research, even as the industry still lacks clear evidence of broad clinical payoff.

Novo NordiskOpenAIAI drug discoverybig pharma
industry

Fierce Biotech’s Big Pharma roundup shows AI is now judged by measurable impact

Big Pharma’s AI story is changing from experimentation to proof. Fierce Biotech’s reporting suggests companies are increasingly willing to point to measurable impact in drug development, dealmaking, and operations rather than simply touting pilot programs.

Fierce Biotech
big pharmaROIdrug development
industry

J&J’s AI Interest Signals Drug Development Is Shifting From Experiment to Strategy

A RAPS roundup suggests Johnson & Johnson is exploring AI as a lever to cut drug development timelines, reflecting a broader pharma trend toward operationalizing AI. The article also notes improving UK biotech investment conditions, hinting at a more active market backdrop.

RAPS.org
Johnson & Johnsonbig pharmaAI strategy
industry

GEN: Lilly’s Expanded AI Footprint Shows Big Pharma Is Building Discovery Capacity Through Portfolios, Not Bets

Genetic Engineering & Biotechnology News frames Lilly’s latest collaboration as part of a broader expansion of its AI footprint. The significance is strategic: large pharma increasingly appears to be treating AI partnerships as a portfolio-building exercise across modalities and programs, rather than as isolated moonshots.

Genetic Engineering and Biotechnology News
LillyAI partnershipsdrug discovery

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.